Unexpectedly, levels of circulating FGF-21 have been found to be higher in people with obesity, T2DM, and NAFLD, when compared to normal individuals [7, 11]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.